PREVIOUS
✖
Colon Cancer Vaccine for Use
September 11 , 2025
32 days
283
0
- Russia’s Federal Medical Biological Agency (FMBA) completed its mRNA-based colon cancer vaccine preclinical trials with high efficacy and safety.
- The vaccine targets colorectal cancer and showed tumor reduction rates between 60% and 80%.
- Colon cancer, also known as colorectal cancer when it includes both the colon and rectum.
- It is a type of cancer that begins in the large intestine (colon), which is part of the digestive system.
Leave a Reply
Your Comment is awaiting moderation.